Core Points - Veradigm LLC experienced a data breach that was discovered around July 1, 2025, involving unauthorized access to customer data [1][3] - The breach likely exposed sensitive personal information, including names, Social Security numbers, contact details, dates of birth, health records, insurance information, payment data, and driver's license numbers [4] Company Overview - Veradigm LLC is a healthcare technology company that provides data-driven tools and solutions aimed at enhancing patient care and reducing healthcare costs [2] Incident Details - The data breach occurred around December 15, 2024, shortly after another security issue affected a different client of Veradigm [3] - The compromised storage account was the entry point for the unauthorized access to customer data [3] Legal Actions - Edelson Lechtzin LLP is investigating potential class action lawsuits for individuals whose sensitive personal data may have been compromised due to the breach [5]

Company Overview - Insperity, Inc. is a human resources and business solutions company that provides payroll, benefits, compliance, and talent management services to small and midsize businesses across the United States [3]. Allegations and Financial Impact - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Insperity due to allegations of providing potentially misleading business information to the investing public [1]. - On August 1, 2025, Insperity disclosed a 70% year-over-year decline in earnings per share for the second quarter of 2025, attributing this decline to rising pharmacy expenses, increased benefit costs, and large insurance claims [4]. - Following the earnings announcement, Insperity's stock price fell by $14.51 per share, or 24.35%, closing at $45.07 per share on August 1, 2025 [4]. - The company also revised down its full-year earnings guidance for 2025 [4].

Core Viewpoint - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Gartner, Inc. due to allegations of misleading business information provided to investors [1][3]. Company Overview - Gartner, Inc. is a research and advisory firm that offers insights, consulting, and business tools to assist companies in making informed decisions in the technology and IT sectors [2]. Allegations and Financial Impact - On August 5, 2025, Gartner reported a slowdown in its contract growth rate, leading to a decrease in its annual revenue forecast from $6.54 billion to $6.46 billion [3]. - The management attributed this downward adjustment to cost-cutting measures implemented to mitigate potential tariff risks [3]. Stock Market Reaction - Following the announcement of the revenue forecast adjustment, Gartner's stock price fell by $92.78 per share, or 27.55%, closing at $243.93 per share on August 5, 2025 [4].

Core Viewpoint - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Lantheus Holdings, Inc. due to allegations of providing misleading business information to investors [1]. Company Overview - Lantheus Holdings, Inc. is a globally recognized company focused on the development, production, and distribution of advanced diagnostic and therapeutic products, with core expertise in oncology and cardiovascular care [3]. Alleged Wrongdoing - On August 6, 2025, Lantheus reported weaker-than-expected second-quarter results, missing earnings and revenue targets. The company cut its full-year 2025 revenue and EPS forecasts, citing tougher competition in the PSMA PET imaging market and strategic pullbacks from certain accounts [4]. - Revenue for the quarter fell to $378 million, down 4.1%, with PYLARIFY sales dropping 8.3% to $250.6 million, both below projections [4]. Market Reaction - Following the news of the disappointing results, Lantheus stock price fell by $20.76 per share, or 28.58%, closing at $51.87 per share on August 6, 2025 [5].

Company Overview - The Trade Desk, Inc. is a global technology company headquartered in Ventura, California, providing a cloud-based platform for advertisers to manage and optimize digital ad campaigns across various formats and devices [3]. Allegations and Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving The Trade Desk, based on allegations of providing misleading business information to investors [1]. - The investigation follows The Trade Desk's announcement of its second-quarter 2025 earnings on August 7, 2025, which missed market expectations, leading to multiple analyst downgrades, including a double downgrade from Bank of America [4]. Financial Performance and Market Reaction - The Trade Desk's second-quarter results raised concerns about rising competition, operational errors, and doubts regarding its ability to sustain long-term growth above 20%, which is critical for its high valuation [4]. - Following the earnings announcement, The Trade Desk's stock price fell by $34.10 per share, or 38.6%, closing at $54.23 per share on August 8, 2025 [5].

Group 1 - FinWise Bank experienced a data security incident involving a former employee accessing sensitive data after their employment ended, with the breach occurring around May 31, 2024, and notification to affected individuals delayed for over 14 months [3][4]. - Compromised data includes personal information such as customers' full names, Dates of Birth, Social Security Numbers, and account numbers [4]. - Edelson Lechtzin LLP is investigating potential class action lawsuits for individuals whose sensitive personal data may have been compromised due to the FinWise data breach [5]. Group 2 - FinWise Bank is a Utah chartered bank that provides "embedded banking" services, assisting non-financial businesses, including fintechs, in offering financial products to consumers and businesses [2].

Core Points - Artivion, Inc. experienced a data breach on or about November 20, 2024, involving unauthorized access to its network [3] - The breach potentially compromised sensitive personal data, including names, Social Security Numbers, driver's license numbers, and direct deposit details [3] - Edelson Lechtzin LLP is investigating the incident and considering a class action lawsuit for affected individuals [4] Company Overview - Artivion, Inc. is a global medical device company based in Kennesaw, Georgia, founded in 1984 and previously known as CryoLife [2] - The company specializes in manufacturing, processing, and distributing medical devices and implantable tissues for cardiac and vascular procedures [2]

Company Overview - PetMed Express, Inc. is an online pet pharmacy that provides prescription and non-prescription medications, supplements, and pet supplies directly to consumers across the United States [3]. Allegations and Stock Impact - On June 10, 2025, PetMed announced a delay in releasing its fourth-quarter and full-year 2025 earnings due to the need for additional time to complete its year-end audit process, resulting in a stock price decline of $0.47, or 11.2%, closing at $3.72 per share on June 11, 2025 [3]. - On July 1, 2025, PetMed disclosed another delay in filing its annual report with the SEC, linked to an internal investigation by the Audit Committee regarding whistleblower complaints about revenue recognition, promotional coupon impacts, and company culture. This announcement led to a further stock price drop of $0.05, or 1.51%, closing at $3.27 per share on the same day [3]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving PetMed, stemming from allegations of providing misleading business information to investors [1].

Core Viewpoint - Centene Corporation is under investigation for potential violations of federal securities laws due to allegations of providing misleading business information, which has led to significant stock price decline following the withdrawal of its earnings guidance [1][4]. Company Overview - Centene is a managed healthcare company that specializes in government-sponsored programs such as Medicaid and Medicare, as well as health insurance plans on individual exchanges and commercial marketplaces [3]. Alleged Wrongdoing - On July 1, 2025, Centene announced its decision to withdraw its 2025 earnings guidance, citing declining market growth in 22 out of the 29 states it operates in. The company indicated that health risks in these states were much higher than previously anticipated in its risk adjustment calculations [4]. - Following this announcement, Centene's stock price dropped by $22.87 per share, representing a 40.37% decline, closing at $33.78 per share on July 2, 2025 [4].

Company Overview - Hims & Hers Health, Inc. is a telehealth and online pharmacy company that provides prescription and over-the-counter medications, mental health services, and personal care products through a direct-to-consumer platform, connecting users with licensed healthcare professionals in the U.S. and the U.K. [3] Allegations and Impact - Edelson Lechtzin LLP is investigating potential violations of federal securities laws involving Hims, stemming from allegations of providing potentially misleading business information to the investing public [1] - On April 29, 2025, Novo Nordisk announced it would sell its weight loss drug Wegovy through Hims' telehealth platform, but on June 23, 2025, Novo Nordisk terminated its partnership with Hims due to concerns about Hims' compliance with laws governing the sale and marketing of compounded drugs [4] - Following the termination of the partnership, Hims' stock price fell by $22.24 per share, or 34.63%, closing at $41.98 per share on June 23, 2025 [4]